126 related articles for article (PubMed ID: 38602289)
1. Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase Acts as a Tumor Suppressor in Oral Squamous Cell Carcinoma.
Etemad-Moghadam S; Mohammadpour H; Emami Razavi A; Alaeddini M
Appl Immunohistochem Mol Morphol; 2024 May-Jun 01; 32(5):249-253. PubMed ID: 38602289
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma.
Zhou J; Yu X; Wang J; Li T; Jin T; Lei D; Pan X
PLoS One; 2015; 10(3):e0119405. PubMed ID: 25793736
[TBL] [Abstract][Full Text] [Related]
3. Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma.
He X; Zhang Z; Li M; Li S; Ren L; Zhu H; Xiao B; Shi R
BMC Cancer; 2015 Aug; 15():575. PubMed ID: 26245343
[TBL] [Abstract][Full Text] [Related]
4. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.
Warfel NA; Newton AC
J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674
[TBL] [Abstract][Full Text] [Related]
5. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
[TBL] [Abstract][Full Text] [Related]
6. MARCH1 silencing suppresses growth of oral squamous cell carcinoma through regulation of PHLPP2.
Liu L; Guo B; Han Y; Xu S; Liu S
Clin Transl Oncol; 2022 Jul; 24(7):1311-1321. PubMed ID: 35122633
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of PHLPP phosphatases in the nervous system.
Mallick A; Sharma M; Dey CS
Mol Cell Neurosci; 2022 Dec; 123():103789. PubMed ID: 36343848
[TBL] [Abstract][Full Text] [Related]
8. PHLPPing through history: a decade in the life of PHLPP phosphatases.
Grzechnik AT; Newton AC
Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
[TBL] [Abstract][Full Text] [Related]
9. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.
Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608
[TBL] [Abstract][Full Text] [Related]
10. Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C.
Xiong X; Li X; Wen YA; Gao T
J Biol Chem; 2016 Nov; 291(48):25167-25178. PubMed ID: 27760826
[TBL] [Abstract][Full Text] [Related]
11. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
Ishibashi O; Akagi I; Ogawa Y; Inui T
Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
[TBL] [Abstract][Full Text] [Related]
12. Suppression of survival signalling pathways by the phosphatase PHLPP.
O'Neill AK; Niederst MJ; Newton AC
FEBS J; 2013 Jan; 280(2):572-83. PubMed ID: 22340730
[TBL] [Abstract][Full Text] [Related]
13. Turning off AKT: PHLPP as a drug target.
Newton AC; Trotman LC
Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697
[TBL] [Abstract][Full Text] [Related]
14. LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
Lee CH; Pan KL; Tang YC; Tsai MH; Cheng AJ; Shen MY; Cheng YM; Huang TT; Lin P
Oncotarget; 2015 Sep; 6(28):25188-201. PubMed ID: 26317789
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.
Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM
J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368
[TBL] [Abstract][Full Text] [Related]
16. On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart.
Lemoine KA; Fassas JM; Ohannesian SH; Purcell NH
Cell Signal; 2021 Oct; 86():110097. PubMed ID: 34320369
[TBL] [Abstract][Full Text] [Related]
17. WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1).
Gangula NR; Maddika S
J Biol Chem; 2013 Nov; 288(48):34545-54. PubMed ID: 24145035
[TBL] [Abstract][Full Text] [Related]
18. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
[TBL] [Abstract][Full Text] [Related]
19. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.
Warfel NA; Niederst M; Stevens MW; Brennan PM; Frame MC; Newton AC
J Biol Chem; 2011 Jun; 286(22):19777-88. PubMed ID: 21454620
[TBL] [Abstract][Full Text] [Related]
20. PHLPP Signaling in Immune Cells.
Lordén G; Lam AJ; Levings MK; Newton AC
Curr Top Microbiol Immunol; 2022; 436():117-143. PubMed ID: 36243842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
